Improving Cardiovascular Outcomes

by | Dec 12, 2025 | News, Whitepapers

New Whitepaper:
IMPROVING CARDIOVASCULAR OUTCOMES AND ECONOMIC EFFICIENCY THROUGH PREDICTIVE & INTERVENTIONAL ARTIFICIAL INTELLIGENCE:

A CASE FOR DELOREAN AI’S CARDIO AI SOLUTION

DeLorean AI analyzed more than 12 million patient records across hypertension, ischemic heart disease, heart failure, and related cardiovascular conditions. The findings are clear: predictive and interventional AI can materially improve clinical outcomes and economic performance for both payers and providers.

87% PREDICTION ACCURACY FOR HEART FAILURE PROGRESSION

Cardio AI identifies patients transitioning from hypertension or ischemic heart disease toward heart failure with 87 percent sensitivity, enabling earlier intervention before costly deterioration occurs.

3+ MILLION PATIENTS IDENTIFIED AS AT RISK

Across the dataset, more than three million patients were flagged as high-risk for progressing toward serious cardiac events, including acute heart failure hospitalization. Even modest improvements in management could translate into billions in avoidable costs annually.
*

REAL-TIME RISK STRATIFICATION ACROSS 12 MILLION+ MEMBERS

Cardio AI continuously stratifies patients into three predictive pathways:
• Likely to worsen
• Stable
• Likely to improve
This enables targeted outreach and proactive clinical action as new EHR data arrives.
}

EARLY IDENTIFICATION OF ACUTE HEART FAILURE WITHIN 90 DAYS

The model predicts which patients are likely to experience acute heart failure hospitalization within 90 days, empowering clinicians to initiate medication adjustments, diagnostics, or specialist referrals before an adverse event. Accuracy improves as longitudinal data accumulates.

HYPERPERSONALIZED NEXT BEST ACTIONS

Cardio AI integrates with any EHR and flags deviations from ACC and AHA clinical guidelines, delivering patient-specific, evidence-based next best actions to support provider decision-making and improve care quality.

HIGH-COST CONDITIONS TARGETED BEFORE ESCALATION

Heart failure patients incur over 350,000 dollars PMPY in the year of diagnosis. Hypertension and hyperlipidemia represent over 50 percent of the population, creating a predictable progression pathway that Cardio AI helps interrupt with timely intervention.

SIGNIFICANT ROI OPPORTUNITY

By reducing progression, acute events, and hospitalizations—even at small percentage improvements—payers and health systems can realize substantial financial savings, consistent with established cost-effectiveness studies for early cardiovascular intervention.

Cardio AI equips providers with the predictive insight and actionable guidance needed to bend both the cost curve and the condition curve.

Read the full whitepaper to see how predictive AI is transforming cardiovascular care:

READ THE WHITEPAPER